Wat beteken "Clear"?
Die dier dra nie die mutasie nie. Dit sal nie die siekte ontwikkel nie en sal dit nie deurgee nie.
Hereditary Equine Regional Dermal Asthenia (HERDA) is a genetic skin disorder affecting horses, primarily Quarter Horses. This DNA test identifies carriers and affected horses, helping breeders make informed decisions to prevent passing HERDA to offspring. Early detection through HERDA DNA testing ensures better management and care for at-risk horses. By using this test, horse owners can maintain healthier bloodlines and reduce the incidence of this debilitating condition. Accurate HERDA testing supports responsible breeding practices and promotes equine welfare. Stay proactive with HERDA DNA testing to protect your horse’s health and future.
Hereditary Equine Regional Dermal Asthenia (HERDA) is a genetic skin disorder affecting horses, particularly Quarter Horses. It causes the skin to be fragile, easily torn, and slow to heal, leading to painful wounds. A DNA test can identify carriers and affected horses by detecting the specific mutation responsible for HERDA. Early testing helps breeders make informed decisions to prevent passing the condition to offspring. Managing HERDA involves careful handling and avoiding activities that stress the skin.
Hierdie DNS-toets is ingesluit vanaf ons pak Basic — en is ook deel van die pakke Basic, Standard, Advanced, Complete.
Bekyk DNA-toetspakkette →Hereditary Equine Regional Dermal Asthenia (HERDA) is a genetic disorder that primarily affects horses, characterized by skin fragility and susceptibility to injury. This condition is caused by a mutation in the gene responsible for collagen production, leading to poor structural integrity of the skin. Horses with HERDA are prone to developing skin lesions, which can result in scarring and other complications.
The clinical manifestations of HERDA typically become evident as the horse matures. Common symptoms include excessive skin laxity, easily bruised skin, and the formation of open wounds following minimal trauma. These wounds often heal poorly, leading to significant scarring. Affected horses may also exhibit hair loss in the areas where the skin is compromised, further exacerbating their vulnerability to environmental factors.
HERDA is an autosomal recessive condition, meaning that a horse must inherit two copies of the mutated gene—one from each parent—to express the disorder. Horses carrying only one copy of the mutation are considered carriers and typically do not show any clinical signs. Understanding the genetic basis of HERDA is crucial for breeding decisions, as it enables breeders to identify carriers and reduce the incidence of this condition in future generations.
Management of horses diagnosed with HERDA primarily focuses on minimizing the risk of injury and providing appropriate wound care. Since these horses are prone to skin problems, owners are advised to handle them gently and avoid situations that could lead to trauma. Regular veterinary check-ups and prompt treatment of any wounds are essential to maintaining the health and well-being of affected horses.
DNA testing for HERDA plays a vital role in the equine industry, particularly for breeders. By identifying carriers of the HERDA gene, breeders can make informed decisions to prevent the transmission of this condition to offspring. This proactive approach helps to maintain the overall health of the horse population while preserving desirable traits in breeding programs.
Hereditary Equine Regional Dermal Asthenia (HERDA) is a serious genetic condition that affects the skin integrity of horses. Understanding the nature of this disorder, its inheritance patterns, and effective management strategies is essential for horse owners and breeders alike. DNA testing serves as a valuable tool in mitigating the risk of HERDA in future generations, ultimately contributing to the health and vitality of the equine population.
Die dier dra nie die mutasie nie. Dit sal nie die siekte ontwikkel nie en sal dit nie deurgee nie.
Nee. Die dier is oor die algemeen gesond, maar kan die mutasie na sy oordra nageslag.
Dit dra twee gemuteerde kopieë. Kliniese tekens word verwag afhangende van die siekte. Dit moet nie geteel word nie.
Sommige siektes is geslagsgekoppel, so hul uitdrukking wissel na gelang van die dier se geslag.
This DNA test detects the mutation associated with Hereditary Equine Regional Dermal Asthenia (HERDA) in order to identify clear, carrier, or at-risk animals.
DNS-toetse help telers om veiliger parings te beplan en die risiko te verminder dat die mutasie na die nageslag oorgedra word.
Die oorerwingsmodus wat vir hierdie toets gerapporteer word, is outosomaal resessief.
This test analyses the mutation PPIB c.115G/A.
Nie noodwendig nie. Interpretasie hang af van die oorerwingspatroon en die gevolglike genotipe.
Tryon Robert C, White Stephen D, Bannasch Danika L. Homozygosity mapping approach identifies a missense mutation in equine cyclophilin B (PPIB) associated with HERDA in the American Quarter Horse. Genomics. 2007 Jul;90(1):93-102. doi: 10.1016/j.ygeno.2007.03.009. Epub 2007 May 11.
Jou privaatheid, jou keuse
Ons gebruik noodsaaklike koekies om die webwerf te bestuur. Opsionele webkoekies (soos verskaffers van ingebedde inhoud) is by verstek gedeaktiveer en word slegs geaktiveer as jy saamstem. Jy kan enige tyd jou keuse verander deur die "Koekies"-knoppie te gebruik.
Vereis vir kernkenmerke en sekuriteit. Altyd geaktiveer.
Verbeter kenmerke soos voorkeurbesparing of nie-reklame-insluitsels.
Help ons om werfgebruik te verstaan. By verstek gedeaktiveer.
Advertensies/nasporing oor werwe heen (sommige video-/kaarte-inbedings). By verstek gedeaktiveer.